On June 12, 2018, the Fourth Circuit unanimously affirmed a decision excluding expert causation testimony and granting summary judgment in favor of Pfizer on claims that its drug Lipitor can...
To support our implementation of an array of attorney development initiatives, Hollingsworth LLP has joined the Diversity & Flexibility Alliance, a community of industry leaders at law firms, professional services...
“Unpublished data from 2013 in the AHS study showed no association with cancer, but Blair did not alert members of the IARC working group about it, he said in a...
Third Circuit Agrees with Hollingsworth LLP Amicus Brief in Zoloft Case, Affirming Exclusion of Causation Expert
news | June 2, 2017In June 2017, the 3rd Circuit unanimously affirmed a decision excluding expert causation testimony and granting summary judgment in favor of Pfizer on claims that its anti-depressant drug Zoloft can...
In Reclast case, Novartis obtains summary judgment based on Daubert exclusion of causation experts’ testimony.
news | February 10, 2017February 2017 — Hollingsworth LLP flexed its considerable Daubert muscle once again in serial pharma litigation in Jones v Novartis. With the benefit of extensive briefing by Firm partners Stephen...
Donald W. Fowler Named an “Environmental Lawyer of the Year” by Corporate Livewire
news | January 13, 2017Firm partner, Don Fowler, has been named to the 2017 “Environmental Lawyer of the Year” list by Corporate LiveWire‘s M&A Awards. The awards recognize individuals that have consistently shown best...
Hollingsworth LLP is named High Stakes Litigation Law Firm of the Year and Pharmaceutical Products Liability Law Firm of the Year, Washington DC
news | August 9, 2016Global Law Experts (GLE), a premier guide to leading attorneys throughout the world, has named Hollingsworth LLP as the winner in two award categories — High Stakes Litigation Law Firm...
California Supreme Court Grants Petition to Review Innovator and Prior Manufacturer Liability in Pharma Litigation
news | June 10, 2016The California Supreme Court granted Firm client Novartis Pharmaceutical’s petition for review of a California Court of Appeal opinion, which had relied upon Conte v. Wyeth (2008) 168 Cal. App....